The Arg16Gly polymorphism of human β2‐adrenoreceptor is associated with type 2 diabetes in Taiwanese people

objective  The significance of the association of amino terminal polymorphisms in β2‐adrenoreceptor (ADRB2) with obesity and type 2 diabetes is controversial and differs among ethnic groups. In this study, the association of ADRB2 with risk and age of onset of type 2 diabetes has been examined in a Taiwanese population.

[1]  L. Groop,et al.  Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. , 2001, Hypertension.

[2]  L. Groop,et al.  Common variants in the β2-(Gln27Glu) and β3-(Trp64Arg) -adrenoceptor genes are associated with elevated serum NEFA concentrations and Type II diabetes , 2001, Diabetologia.

[3]  Y. Yazaki,et al.  Association Analysis of &bgr;2-Adrenergic Receptor Polymorphisms With Hypertension in Japanese , 2001, Hypertension.

[4]  M. Schwarz,et al.  TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis , 2000, Thorax.

[5]  A. Mokdad,et al.  The spread of the obesity epidemic in the United States, 1991-1998. , 1999, JAMA.

[6]  J. Manson,et al.  Annual deaths attributable to obesity in the United States. , 1999, JAMA.

[7]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[8]  Lark,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[9]  K. Yamada,et al.  Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus (Short Communication) , 1999, Diabetologia.

[10]  J. Peters,et al.  Environmental contributions to the obesity epidemic. , 1998, Science.

[11]  D. Allison,et al.  The search for human obesity genes. , 1998, Science.

[12]  P. Eriksson,et al.  Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. , 1997, The Journal of clinical investigation.

[13]  K. Flegal,et al.  Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria , 1997, Diabetes Care.

[14]  A. Koyanagi,et al.  Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. , 1997, Diabetes research and clinical practice.

[15]  J. Oppert,et al.  The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts. , 1996, The Journal of clinical investigation.

[16]  T. Kurabayashi,et al.  The β3-Adrenergic Receptor Gene Trp64Arg Mutation is Overrepresented in Obese Women: Effects on Weight, BMI, Abdominal Fat, Blood Pressure, and Reproductive History in an Elderly Australian Population , 1996, Diabetes.

[17]  M. Berlan,et al.  In situ assessment of the role of the β1, β2‐ and β3‐adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue , 1996 .

[18]  K. Silver,et al.  A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. , 1995, Biochemical and biophysical research communications.

[19]  S. Rössner,et al.  Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. , 1995, Clinical science.

[20]  K. Clément,et al.  Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity , 1995 .

[21]  F. Lönnqvist,et al.  Demonstration of an in vivo functional beta 3-adrenoceptor in man. , 1995, The Journal of clinical investigation.

[22]  F. Lönnqvist,et al.  A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. , 1995, The Journal of clinical investigation.

[23]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[24]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.

[25]  M Lafontan,et al.  Fat cell adrenergic receptors and the control of white and brown fat cell function. , 1993, Journal of lipid research.

[26]  S. Liggett,et al.  Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. , 1993, American journal of respiratory cell and molecular biology.

[27]  M. Permutt,et al.  Glucokinase and NIDDM: A Candidate Gene That Paid Off , 1992, Diabetes.

[28]  M. Thun,et al.  Body-Mass Index and Mortality in a Prospective Cohort of US Adults , 2000 .

[29]  重本 里美,et al.  Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus , 1999 .